![Gustav Christensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Christensen
Präsident bei
Phytera, Inc.
Profil
Gustav A. Christensen is currently Chairman at Morphic Therapeutic, Inc. and President, Treasurer & Director at Phytera, Inc. Former roles include Chairman at Morphic Holding, Inc. (2016–2024), Independent Director at Generation Bio Co. (2017–2026), President, Chief Executive Officer & Director at Dyax Corp.
(2011–2016), Managing Director at Apeiron Partners LLC (2005–2007), Vice President-Business Development at Genetics Institute LLC (1983–1988), Vice President-Operations Fenwal Laboratories at Baxter International, Inc. (1976–1983), Chairman at Alpha-Beta Technology, Inc., President at ImmuLogic Pharmaceutical Corp., Advisor at BioVentures Investors, and Member-Management Board at Alantos Pharmaceuticals AG.
Education includes graduate studies at the University of Aarhus and an MBA from Harvard Business School.
Aktive Positionen von Gustav Christensen
| Unternehmen | Position | Beginn |
|---|---|---|
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | Präsident | - |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Vorsitzender | - |
Ehemalige bekannte Positionen von Gustav Christensen
| Unternehmen | Position | Ende |
|---|---|---|
| GENERATION BIO CO. | Direktor/Vorstandsmitglied | 06.02.2026 |
| MORC HOLD | Vorsitzender | 16.08.2024 |
| DYAX CORP. | Vorstandsvorsitzender | 22.01.2016 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Private Equity Investor | 31.03.2009 |
Apeiron Partners LLC
 Apeiron Partners LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01.01.2007 |
Ausbildung von Gustav Christensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products | Electronic Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | Commercial Services |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alantos Pharmaceuticals AG
 Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Partners LLC
Apeiron Partners LLC Investment ManagersFinance Provides investment advice | Finance |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
